Publications scientifiques

2602 PUBLICATIONS

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

ANNÉE2021

JOURNALFrontiers in oncology

PREMIER AUTEURTaillandier L

TITREWhat Does Quality of Care Mean in Lower-Grade Glioma Patients: A Precision Molecular-Based Management of the Tumor or an Individualized Medicine Centered on Patient's Choices?

ANNÉE2021

JOURNALFrontiers in cell and developmental biology

PREMIER AUTEURNeyrinck-Leglantier D

TITREZO-1 Intracellular Localization Organizes Immune Response in Non-Small Cell Lung Cancer.

ANNÉE2020

JOURNALGenes & cancer

PREMIER AUTEURGrandvallet C

TITREAutophagy is associated with a robust specific transcriptional signature in breast cancer subtypes.

ANNÉE2020

JOURNALBiomolecules

PREMIER AUTEURBretaudeau C

TITREAG-9, an Elastin-Derived Peptide, Increases In Vitro Oral Tongue Carcinoma Cell Invasion, through an Increase in MMP-2 Secretion and MT1-MMP Expression, in a RPSA-Dependent Manner.

ANNÉE2020

JOURNALInternational journal of surgery case reports

PREMIER AUTEURMarchand Crety C

TITREPrimary gastric synovial sarcoma: A case report and literature review.

ANNÉE2020

JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

PREMIER AUTEURKhadige M

TITRE[Lung cancer and pulmonary metastasis treated by stereotactic radiosurgery: Evaluation of the relevance of realisation of 3 4D CT by the RPM technique].

ANNÉE2020

JOURNALDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

PREMIER AUTEURTaïeb J

TITREAvelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial.

ANNÉE2020

JOURNALBulletin du cancer

PREMIER AUTEURSchraub S

TITRE[Impact of patient testimony in the education of medicine and pharmacy students].

ANNÉE2020

JOURNALDigestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

PREMIER AUTEUREvrard C

TITREPRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancer.

ANNÉE2020

JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

PREMIER AUTEURKuntz L

TITRE[Pelvic irradiation and hematopoietic toxicity: A review of the literature].